Skip to content
2000
Volume 19, Issue 3
  • ISSN: 1871-5230
  • E-ISSN: 1875-614X
file format pdf download PDF

Abstract

The anti-IgE Omalizumab may be helpful to treat clopidogrel hypersensitivity without stopping thienopyridine administration in patients requirining continuous antiplatellet therapy after coronary stent placement.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aiaamc/10.2174/1871523018666190522105055
2020-09-01
2025-09-02

  • From This Site

    /content/journals/aiaamc/10.2174/1871523018666190522105055
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/aiaamc/10.2174/1871523018666190522105055
Loading

  • Article Type:     Case Report
Keyword(s): Clopidogrel; omalizumab; prasugrel; thienopyridines; ticagrelor; urticaria

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test